ArticleObesity surgery2026
Metabolic and Bariatric Surgery vs. Dietary Counseling in Adults with Severe Obesity: Risk of De Novo Malignancy in a Propensity-Matched Multicentered Real-World Analysis.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a major driver of cancer incidence and mortality through insulin resistance, chronic inflammation, adipokine dysregulation, and hormonal pathways. While metabolic and bariatric surgery (MBS) is known to reduce weight and improve metabolic dysfunction, its impact on incident malignancy compared with structured non-surgical management remains incompletely defined.
methodsWe conducted a retrospective cohort study using the TriNetX federated electronic health record network. Adults aged ≥ 18 years with BMI ≥ 35 kg/m² and no prior malignancy were included. Patients undergoing MBS were compared with individuals receiving structured dietary counseling without prior MBS. Propensity score matching incorporated demographic factors, cardiometabolic comorbidities, liver disease, tobacco and alcohol use, hormone exposure, immunosuppressive therapy, and cancer screening encounters. Primary outcomes were incident obesity-related malignancies. Secondary outcomes included non-obesity-related cancers, solid tumors, and hematologic malignancies. Cox proportional hazards models estimated hazard ratios (HR) with 95% confidence intervals (CI) over 5 years of follow-up.
resultsAfter matching, cohorts were well balanced. Obesity-related malignancies occurred in 1.0% of MBS patients versus 1.2% of diet counseling patients (HR 0.775, 95%CI 0.708, 0.847). Significant reductions were observed for breast, colorectal, endometrial, pancreatic, and liver cancers. Non-obesity-related malignancies occurred in 1.7% versus 1.9% (HR 0.784, 0.732-0.841), with lower lung cancer risk (HR 0.498, 0.377-0.657). Overall solid tumor incidence was 2.2% versus 2.5% (HR 0.801, 0.754, 0.851). Hematologic malignancies occurred in 0.26% versus 0.28% (HR 0.824, 0.689-0.984).
conclusionsIn a rigorously matched contemporary cohort, MBS was associated with reduced risk of obesity-related, non-obesity-related, solid, and hematologic malignancies compared with structured dietary counseling.
Indexed as
Identifiers
42249237What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.